Catherine Bomberger
Internal Medicine · Macon, GANPI 1124135678
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $902 and has fallen 90.3% since, to $87 in 2022.
Across 149 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$488
- Amgen$292
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$175
- AstraZeneca$146
- Supernus Pharmaceuticals, Inc.$132
- Takeda Pharmaceuticals U.S.A., Inc.$122
- plus $830 from 27 others
What the payments were for
- Food & beverage$2,186100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $488 |
| Amgen | 17 | $292 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $175 |
| AstraZeneca | 10 | $146 |
| Supernus Pharmaceuticals, Inc. | 12 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $122 |
| Grifols USA, LLC | 6 | $94 |
| Eisai Inc. | 4 | $70 |
| Astellas Pharma US Inc | 3 | $57 |
| Arbor Pharmaceuticals, Inc. | 4 | $52 |
| Biohaven Pharmaceuticals, Inc. | 3 | $50 |
| Aytu Biopharma, Inc. | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Novo Nordisk | 3 | $40 |
| Pfizer | 2 | $35 |
| Radius Health, Inc. | 2 | $35 |
| Abbott | 2 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Bausch Health US, LLC | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Adlon Therapeutics L.p. | 2 | $23 |
| Novartis | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| GSK | 1 | $15 |
| Gilead | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Merz North America, Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
| Merck | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$2,186 in reported general payments places this provider in the 75th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Macon
- Lesley CownMacon$36K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.